Evidence map›Paper›PMID 37254075›Full record

ArticleBMC public health2023

Identification of urgent gaps in public and policymaker knowledge of heart failure: Results of a global survey.

Carolyn S P Lam, Ed Harding, Marc Bains, Alex Chin, Naresh Kanumilli, Mark C Petrie, Paula Pohja-Hutchison, Jiefu Yang, Javed Butler

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carolyn S P LamNational Heart Centre Singapore, Duke-NUS Medical School, 169857, Singapore, Singapore. carolyn.lam@duke-nus.edu.sg.
Ed HardingThe Health Policy Partnership, WC2N 4JS, London, UK.
Marc BainsThe HeartLife Foundation, V5X 1E7, Vancouver, BC, Canada.
Alex ChinAstraZeneca, Global Medical Affairs, 20878, Gaithersburg, MD, USA.
Naresh KanumilliNorthenden Group Practice, M22 4DH, Northenden, Manchester, UK.
Mark C PetrieInstitute of Cardiovascular and Medical Sciences, The University Court of the University of Glasgow, G12 8QQ, Glasgow, UK.
Paula Pohja-HutchisonAstraZeneca, Global Corporate Affairs, CB2 8PA, Cambridge, UK.
Jiefu YangDepartment of Cardiology, Beijing Hospital, National Center of Gerontology China, 100730, Beijing, China.
Javed ButlerDepartment of Medicine, University of Mississippi Medical Center, 39216, Jackson, MS, USA. butlzih@gmail.com.

Funding

British Heart Foundation RE/18/6/34217
6 · The paper itself

Abstract

backgroundDespite advances in the treatment of heart failure (HF) with reduced ejection fraction, people with HF continue to have a high risk of mortality and hospitalisation. Patients also suffer from poor quality of life, with reduced societal and economic participation. The burden of HF on patients and healthcare systems is extraordinary, yet awareness remains low. This survey was conducted to identify gaps in general public and policymaker knowledge around HF.

methodsA closed-question web-based survey of the general public and policymakers was conducted between February and October 2020. Study outcomes assessed the participants' awareness and understanding of HF symptoms, risk factors and mortality, and views around hospital admissions in their country. Responses were collected using multiple-choice questions.

resultsThe survey was completed by 26,272 general public respondents in 13 countries and 281 government and public sector policymakers in nine countries. While 99% of general public respondents had heard of HF, their understanding of the condition and its symptoms was poor, and only 6% identified that shortness of breath, fatigue, and leg swelling were the main symptoms of HF. Of policymaker respondents, 14% identified HF as the leading cause of avoidable hospitalisations, and only 4% recognised that ~ 87% of government spending on HF is related to hospitalisations.

conclusionsMajor gaps were identified in the understanding of HF and the burden it places on patients and their caregivers, healthcare systems and society. This study confirms an ongoing need for national policy strategies and investment to raise awareness of the importance of HF prevention, early diagnosis, and implementation of effective treatments to reduce hospitalisations and death.

Indexed as

Heart FailureQuality of LifeHospitalizationHumansSurveys and QuestionnairesEarly diagnosisHealthcareHeart failurePublic health

Identifiers

PMID37254075
PMCPMC10227786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.